Autopsy report · NCT05059080
A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study
Cause of deathFunding or business
“Based on program revaluation and in agreement with the co-development partner the sponsor took the decision to terminate this study.”
Life of this trial
- Registered 3 months after it had already started.
- Ran for about 9 months before it stopped.
- 72 participants enrolled.
- Results were posted on the registry 1 year 4 months after it ended.
Vital statistics
- Status
- Terminated
- Sponsor
- Hoffmann-La Roche
- Sponsor type
- Industry
- Conditions
- COVID-19; Long COVID
- Participants
- 72
- Sites
- 35
- Countries
- Argentina, Belgium, Brazil, Denmark, Germany, Mexico, Romania, Switzerland, Turkey (Türkiye), Ukraine
Trials that died the same way
- Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers
“Sponsor decision to terminate the study” - Study of RP-6306 With FOLFIRI in Advanced Solid Tumors
“Sponsor decided to terminate the study” - The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
“Business decision by sponsor to terminate the study” - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors(MEETCD8-001)
“Due to adjustments in the sponsor's development strategy, it has been decided to terminate the study.” - A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
“Voluntarily terminate the study since the sponsor's development strategy was adjusted.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.